Professor Katie Watson joins Ethics Talk to consider key questions about clinical and legal risk management for clinicians trying keep patients safe and for patients with complex pregnancies trying to stay alive.
Guddi Singh, MB BChir, MPH, John Owens, MA, PhD, and Alan Cribb, PhD
Co-creation initiatives in health care have potential to support health equity but require a redistribution of power and a common vision in order to succeed.
AMA J Ethics. 2017;19(11):1132-1138. doi:
10.1001/journalofethics.2017.19.11.msoc1-1711.
A history of device oversight by the US Food and Drug Administration traces regulatory changes in response to injuries caused by Dalkon Shield intrauterine devices.
AMA J Ethics. 2021;23(9):E712-720. doi:
10.1001/amajethics.2021.712.
Most women requesting pregnancy termination have already decided to undergo an abortion, but some jurisdictions have implemented strategies to induce doubt and regret.
AMA J Ethics. 2020;22(9):E792-795. doi:
10.1001/amajethics.2020.792.
Despite the natural desire in obstetrics for a happy outcome, sometimes the common aggressive interventions will not help maintain a pregnancy until viability.
When deciding whether a pregnant woman will take antidepressants that pose a slight risk to the fetus, the patient and doctor must each make value-based determinations about whether absolute protection of the fetus is more important than preventing the mother’s probable suffering.
Refusal of pediatric euthanasia can be considered iatrogenic insofar as it inadvertently prolongs patient suffering, but attitudes differ cross-culturally.
AMA J Ethics. 2017;19(8):802-814. doi:
10.1001/journalofethics.2017.19.8.msoc1-1708.